SS

Sheikh Saddam Sheikh Nizam

Active Director Director DIN 10482235
DIN 10482235 First appointment Jan 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sheikh Saddam Sheikh Nizam

Data last updated:

Sheikh Saddam Sheikh Nizam is a Director at Medwella Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10482235
Primary Designation Director
Industry Paper
First Appointment 29 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jan 20242024Active

Board colleagues of Sheikh Saddam Sheikh Nizam

Directorship timeline

Open interactive timeline →
Medwella Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sheikh Saddam Sheikh Nizam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheikh Saddam Sheikh Nizam

Sheikh Saddam Sheikh Nizam currently holds 1 directorship: Medwella Pharmaceuticals Private Limited (Director, since 29 Jan 2024).

Sheikh Saddam Sheikh Nizam was first appointed on 29 Jan 2024 as Director at Medwella Pharmaceuticals Private Limited.

The current boards of Sheikh Saddam Sheikh Nizam's companies include Abdul Rub Shaikh Abdul Gaffar Shaikh (Medwella Pharmaceuticals Private Limited), Shaikh Sadique Shaikh Matin (Medwella Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available